Brief: Rani Therapeutics Announces Partnership With Progen
June 24 (Reuters) - Rani Therapeutics Holdings Inc
RANI.O :
* RANI THERAPEUTICS ANNOUNCES PARTNERSHIP WITH PROGEN ON
DEVELOPMENT OF ORAL OBESITY TREATMENT
* RANI THERAPEUTICS & PROGEN CO-DEVELOP RT-114
* RANI & PROGEN PARTNERSHIP WITH NO UPFRONT PAYMENT
* RANI THERAPEUTICS: CO, PROGEN TO SHARE RESPONSIBILITIES
FOR
RT-114, INCLUDING 50/50 COST & REVENUE SHARE
Source text for Eikon: ID:nGNX8l7Hv3
Further company coverage: RANI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rani Therapeutics Holdings
See all newsRani Therapeutics Q2 net loss narrows as revenue rises helped by Chugai agreement
Brief: Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Pegbio Co Enters MoU With Rani Therapeutics
Brief: Rani Therapeutics Announces R&D Collaboration With PegBio
Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition